Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system

Leukemia

Volumn 15, Issue 9, 2001, Pages 1433-1441

  Koistinen, P ^a   Siitonen, T ^a   Mantymaa P ^a   Saily M ^a   Kinnula, V ^a   Savolainen, E R ^a   Soini, Y ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Akt kinase; AML; eNOS; Flk 1 KDR; PI3 K; VEGF

Indexed keywords

NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT VASCULOTROPIN; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BLAST CELL; BONE MARROW; CELL GROWTH; CLINICAL ARTICLE; CLONOGENESIS; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO DEVELOPMENT; ENDOCRINE SYSTEM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEUKEMIA CELL LINE; MALIGNANT NEOPLASTIC DISEASE; PARACRINE SIGNALING; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0034857310     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402217     Document Type: Article

References (57)

1. Mammalian nitric oxide synthases
2. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
3. Nitric oxide. A cytotoxic activated macrophage effector molecule
4. Nitric oxide physiology, pathophysiology and pharmacology
5. Nitric oxide as a secretory product of mammalian cells
6. Nitric oxide synthases: Roles, tolls, and controls
7. Nitric oxide-cyclic GMP signal transduction system
8. Nitric oxide synthase modulates angiogenesis in response to ischemia
9. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
10. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)
11. VEGF upregulates eNOS message, protein, and NO production in human endothelial cells
12. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
13. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
14. The Akt kinase signals directly to endothelial nitric oxide synthase
15. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway
16. Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through Flk-1/KDR activation of c-Src
17. Regulation of angiogenesis via vascular endothelial growth factor receptors
18. Nitric oxide supression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha
19. Effect of nitric oxide production and oxygen tension on progenitor preservation in ex vivo culture
20. The effect of redox-related species of nitrogen monoxide on transferrin and iron uptake and cellular proliferation of erythroleukemia (K562) cells
21. Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide
22. Nitric oxide modulation of human leukemia cell differentiation and gene expression
23. Role of nitric oxide in the anti-tumoral effect of retinoic acid and 1,25-dihydroxyvitamin D3 on human promonocytic leukemic cells
24. Nitric oxide inhibits Fas-induced apoptosis
25. Nitric oxide inhibits APO-1/Fas-mediated cell death
26. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity
27. Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-1 infected cell lines: Clinical features and apoptosis by NOS inhibitor
28. Mechanisms involved in the pro-and anti-apoptotic role of NO in human leukemia
29. A common precursor for hematopoietic and endothelial cells
30. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
31. Conditional requirement for the Flk-1 receptor in the in vitro generation of early hematopoietic cells
32. In vitro hematopoietic and endothelial potential of flk-1-/-embryonic stem cells and embryos
33. KDR receptor: A key marker defining hematopoietic stem cells
34. Stem cell renewal and determination during clonal expansion in normal and leukaemic haemopoiesis
35. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation
36. Expression of Flt4 and its ligand VEGF-C in acute myeloid leukemia
37. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PIGF) in regulating human haemapoietic cell growth
38. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia
39. Endothelial growth factors and their receptors in human leukemia
40. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
41. Neutralizing MoAb to VEGF receptors inhibit proliferation and migration of a subset of human leukemias through interaction with VEGFR-2 (KDR) and VEGFR-1 (FLT-1)
42. Angiogenesis in myelodysplastic syndromes
43. Evidence of increased angiogenesis in patients with acute myeloid leukemia
44. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
45. Increased angiogenesis in the bone maroow of patients with acute myeloid leukemia
46. Expression of a retinoic acid receptor gene in myeloid leukemia cells
47. Proposed revised criteria for the classification of acute myeloid leukemia
48. Characteristics of NaF-induced differentiation of HL-60 cells
49. Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells
50. Nitric oxide and its role in apoptosis
51. Nitric oxide and cell death
52. The level of vascular endothelial growth factor receptor-2 in peripheral blood chronic lymphocytic leukemia (CLL) cells correlates with patient survival
53. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in post-capillary endothelium
54. Mechanism of activation of protein kinase B by insulin and IGF-1
55. Akt promotes survival by phosphorylating and inhibiting a forkhead transcription factor
56. Control of apoptosis by Rel/NF-kB transcription factors
57. New insights into tumor supression: PTEN supresses tumor formation by restraining the phosphoinositide 3-kinase/Akt pathway